Stockscreener 앱 받기
440.59
0.10%
-0.96
전일 마감가:
$441.55
열려 있는:
$441.94
하루 거래량:
85,753
Relative Volume:
0.33
시가총액:
$5.85B
수익:
$2.54B
순이익/손실:
$259.78M
주가수익비율:
24.01
EPS:
18.3497
순현금흐름:
$377.12M
1주 성능:
+1.52%
1개월 성능:
+18.21%
6개월 성능:
-0.14%
1년 성능:
-21.43%
1일 변동 폭
$438.10
$445.46
1주일 범위
$431.14
$446.84
52주 변동 폭
$365.20
$581.20
Chemed Corp Stock (CHE) Company Profile
명칭
Chemed Corp
전화
(513)762-6690
주소
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, DVA, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
441.06 | 5.86B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
394.22 | 87.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
174.53 | 15.33B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
197.57 | 12.75B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.71 | 12.09B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.18 | 10.36B | 6.07B | 793.80M | 464.40M | 5.9914 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-27 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-09-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-07-25 | 개시 | Jefferies | Hold |
| 2020-03-11 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | 재확인 | BofA/Merrill | Buy |
| 2018-10-12 | 개시 | BofA/Merrill | Buy |
| 2017-08-28 | 개시 | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | 재확인 | Oppenheimer | Outperform |
| 2015-10-26 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | 재확인 | Oppenheimer | Outperform |
| 2015-07-27 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | 재확인 | Oppenheimer | Outperform |
| 2014-09-23 | 재확인 | Oppenheimer | Outperform |
| 2014-06-10 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | 재확인 | Oppenheimer | Outperform |
| 2013-09-10 | 재확인 | Deutsche Bank | Hold |
| 2011-03-04 | 재확인 | Barclays Capital | Underweight |
| 2011-02-17 | 재확인 | Oppenheimer | Outperform |
| 2011-02-17 | 재확인 | RBC Capital Mkts | Sector Perform |
모두보기
Chemed Corp 주식(CHE)의 최신 뉴스
Trading Systems Reacting to (CHE) Volatility - Stock Traders Daily
Chemed Corporation 8-K SEC Filing Summary for May 18, 2026 – Key Entity Information and Voting Results - Minichart
Chemed stockholders elect board, ratify auditor, reject executive pay plan - Investing.com
Chemed Corporation Stockholders Elect Directors, Ratify Accountants, and Declare Quarterly Dividend - Quiver Quantitative
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend - GlobeNewswire
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend - GlobeNewswire Inc.
Chemed Corp (CHE) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential with a 2.75% Upside - DirectorsTalk Interviews
Chemed Conference Webcast Puts Dual Businesses And Valuation In Focus - Yahoo Finance
Chemed Corp stock (US1638321034): hospice and plumbing specialist draws investor focus after latest - AD HOC NEWS
Chemed Corp stock (US1638321034): Presentation at RBC Healthcare Conference - AD HOC NEWS
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference - Caledonian Record
Chemed Corp (CHE) Stock Analysis: Navigating the Healthcare Sector with a 5.24% Potential Upside - DirectorsTalk Interviews
C WorldWide Group Holding A S Invests $2.19 Million in Chemed Corporation $CHE - MarketBeat
How Chemed Corp (CHE) Affects Rotational Strategy Timing - Stock Traders Daily
CHE SEC FilingsChemed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[144] CHEMED CORP SEC Filing - Stock Titan
Chemed director Patrick P. Grace sells $25,546 in stock By Investing.com - Investing.com Australia
Chemed director Patrick P. Grace sells $25,546 in stock - Investing.com
Chemed Corp (CHE) director sells 60 shares at $425.78 - Stock Titan
Chemed Corp stock (US1638321034): Home health and hospice growth continues to drive earnings - AD HOC NEWS
CHE Stock Price, Quote & Chart | CHEMED CORP (NYSE:CHE) - ChartMill
Chemed Corporation $CHE Shares Acquired by UBS Group AG - MarketBeat
Sadness This Mother's Day? VITAS® Healthcare Launches Free, Nationwide Mother's Day Grief Helpline - Quantisnow
The company behind VITAS and Roto-Rooter presents in Las Vegas May 12 - Stock Titan
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026 - GlobeNewswire
Van Berkom & Associates Inc. Acquires 4,056 Shares of Chemed Corporation $CHE - MarketBeat
Chemed Corporation $CHE Shares Acquired by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Chemed CEO Kevin McNamara sells $842,260 in Che stock - Investing.com India
Chemed CEO Kevin McNamara sells $842,260 in Che stock By Investing.com - Investing.com Australia
Chemed (CHE) CEO Kevin McNamara sells 2,000 shares at $421.13 average - Stock Titan
Chemed Corp (CHE) Stock Analysis: Navigating Healthcare Growth with a 5.77% Upside Potential - DirectorsTalk Interviews
Chemed (NYSE:CHE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Chemed Corporation (NYSE: CHE) affiliate files Form 144 to sell 1,000 shares - Stock Titan
Kevin McNamara reports Common stock sales (CHE) on Form 144 - Stock Titan
Vanguard Capital Management (CHE) reports 744,055 shares, 5.40% stake - Stock Titan
Vanguard holds 817,550 Chemed shares (CHE) — 5.93% stake - Stock Titan
(CHE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Chemed (NYSE:CHE) Raised to Hold at Zacks Research - MarketBeat
CHE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Chemed 10-Q: Revenue $657.5M, EPS $4.84 - TradingView
Chemed (NYSE: CHE) posts Q1 2026 revenue growth with lower profit - Stock Titan
Chemed Q1 Earnings Call Highlights - MarketBeat
CHE Stock Up Following Q1 Earnings & Revenue Beat, Margins Down - Yahoo Finance
RBC Capital raises Chemed stock price target on strong results By Investing.com - Investing.com Nigeria
Chemed Corp (CHE) Stock Analysis: Investor Outlook On Healthcare's Resilient Performer - DirectorsTalk Interviews
RBC Capital raises Chemed stock price target on strong results - Investing.com
VITAS posts strong earnings, revenue growth in 2026 Q1 - McKnights Home Care
Ave Maria Growth Fund's Chemed Corp(CHE) Holding History - GuruFocus
Abacus FCF Advisors LLC Acquires New Holdings in Chemed Corporation $CHE - MarketBeat
Sensient Technologies, Chemed, AMD, Arm and other big stocks moving higher on Friday - MSN
Why Chemed (CHE) Stock Is Up Today - Yahoo Finance
Chemed Corp (CHE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.94%
1.27%
자본화:
|
볼륨(24시간):